not losing weight on glp 1 Why Am I GLP-I Drugs? Wegovy, Zepbound, etc Optimizing GLP-1 Weight Loss: Effective

They stand up to any scientific scrutiny

In 2024, we also saw unprecedented willingness by large numbers of patients to pay out of pocket, even in European markets, as public coverage of AOMs is still limited, at best, and more often non-existent

Hansoh Pharma will receive an upfront payment of $112 million and is eligible to receive up to $1.9 billion in milestone payments associated with the development, regulatory approval and

When appetite decreases, nutrition has to work harder

These milestones will redefine how obesity care is delivered, marking a turning point that will shape the markets trajectory for 2026 and the years to come

In November 2025, the Trump administration announced landmark agreements with Eli Lilly and Novo Nordisk reducing the monthly price of GLP-1 weight-loss drugs from over $1,000 to as low as $245 for eligible patients